Rapid Detection of blaKPC in Carbapenem-Resistant Enterobacterales Based on CRISPR/Cas13a

Mingjun Liang1, Bin Xiao2, Lidan Chen1

  • 1Department of Laboratory Medicine, General Hospital of Southern Theater Command, No. 111, Liuhua Road, Yuexiu District, Guangzhou City, 510010, Guangdong Province, China.

Current Microbiology
|September 22, 2023
PubMed

Insights

A new RPA-Cas13a assay rapidly detects the blaKPC gene, crucial for carbapenem resistance in Enterobacterales. This simple, one-hour test aids in controlling challenging superbug infections.

Area of Science:

  • Molecular Biology
  • Antimicrobial Resistance
  • Diagnostic Development

Background:

  • Klebsiella pneumoniae carbapenemase (KPC) is a key enzyme driving carbapenem resistance in Enterobacterales.
  • Infections caused by carbapenem-resistant Enterobacterales (CREs) pose significant treatment challenges.
  • Rapid and accurate KPC detection is essential for controlling CRE prevalence.

Purpose of the Study:

  • To develop a novel, rapid, and accurate method for detecting the blaKPC gene.
  • To establish a recombinase polymerase amplification (RPA) and CRISPR/Cas13a-based assay for KPC detection.

Main Methods:

  • Developed a blaKPC detection assay using recombinase polymerase amplification (RPA) and CRISPR/Cas13a with fluorophore activation (RPA-Cas13a).
  • Optimized amplification primers for blaKPC and determined the lower limit of detection using recombinant plasmids.
  • Validated the assay on 57 blaKPC-positive CRE strains and 311 sputum samples.

Main Results:

  • Achieved a lower limit of detection of approximately 2.5 copies/μL for the blaKPC gene.
  • The RPA-Cas13a assay demonstrated 96.5% sensitivity and 100% specificity against DNA sequencing.
  • Results from 311 sputum samples showed high consistency (Kappa = 0.978) between the assay and antibiotic susceptibility testing.

Conclusions:

  • The RPA-Cas13a system offers a simple, efficient, one-hour method for detecting the blaKPC gene.
  • This technology can aid in the rapid identification of potentially fatal antibiotic resistance genes.
  • The assay shows promise for controlling the spread of carbapenem-resistant superbugs.

Related Concept Videos

CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
39
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
43